STATCenter·
STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.
Read at STAT →
Health · 1 sources covering this
STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/f6d9b203dffe242dc7b45eea00c9653508e58f17" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: After two deaths in autoimmune cell therapy trial, Artiva is shutting down"></iframe>
